Drug treatment of epilepsy

BMJ

Volumn 318, Issue 7176, 1999, Pages 106-

  Feely, Morgan ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN;

DROWSINESS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG INTOXICATION; DRUG MONITORING; EPILEPSY; GAIT DISORDER; HUMAN; PRIORITY JOURNAL; RASH; SEIZURE; SHORT SURVEY; SIDE EFFECT; SPINA BIFIDA; TERATOGENESIS; TREMOR; VISUAL FIELD DEFECT; WEIGHT GAIN;

ACETIC ACIDS; AMINES; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BARBITURATES; BENZODIAZEPINES; CLONAZEPAM; CYCLOHEXANECARBOXYLIC ACIDS; DIETHYLCARBAMAZINE; EPILEPSY; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; VALPROIC ACID; VIGABATRIN;

EID: 85007669728     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7176.106     Document Type: Article

References (19)

1. Dichter MA. The epilepsies and convulsive disorders. In: IsselbracherKJ,BraunwaldE,WilsonJD,MartinJB,FacuiAS,KasperDL, eds. Harrison's principles of internal medicine. 13th ed., Vol 2 New York: McGraw-Hill, 1994: 2223-2233.
2. Richens A, Perucca E. General principles in the drug treatment of epilepsy. In: A textbook of epilepsy. 4th ed. Edinburgh: Churchill Livingstone, 1993.
3. Brodie MJ, Dichter MA. Established antiepileptic drugs. Seizure 1997; 6: 159-174.
4. Craig I, Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind comparative study. Epilepsia 1994; 35: 381-390.
5. Roberts SJ, Feely M, Bateman DN. Prescribing of anti-epileptic drugs in the northern and Yorkshire region 1992-1995. Seizure 1998; 7: 127-132.
6. Dichter MA, Brodie MA. New antiepileptic drugs. N Engl J Med 1996; 334: 1583-1590.
7. Stephen LJ, Brodie MJ. New drug treatments for epilepsy. Prescribers J 1998; 38: 98-106.
8. Brown TR, Mattson TH, Penry JK, Smith DB, Treiman DM, Wilder BJ, et al. A multicentre study of vigabatrin for drug-resistant epilepsy. Br J Clin Pharmacol 1989; 27(suppl): 95-100S.
9. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigime and carbamazepine in newly diagnosed epilepsy. Lancet 1995; 345: 476-479.
10. UK Gabapentin Study Group. Gabapentin in partial epilepsy. Lancet 1990; 335: 114-117.
11. The US Gabapentin Study Group No 5. Gabapentin as add-on therapy in refractory partial epilepsy. Neurology 1993; 43: 2292-2298.
12. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400 and 600 mg daily dosages. Neurology 1996; 46: 1684-1690.
13. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996; 313: 1169-1174.
14. Brodie MJ. Lamotrigine versus other antiepileptic drugs: a star rating system is born. Epilepsia 1994; 35: S41-S46.
15. Committee on Safety of Medicines, Medicines Control Agency. Vigabatrin (Sabril) and visual field defects. Curr Probl Pharmacovigilence 1998; 24: 1.
16. Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984; 47: 1279-1282.
17. British Epilepsy Association. The treatment of epilepsy- patient's viewpoint (survey results). Leeds: British Epilepsy Association, 1996.
18. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures. N Engl J Med 1992; 327: 765-771.
19. De Silva M, McArdle B, McGowan M, Hughes E, Stewart J, Neville BG, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996; 347: 709-713.